![]() |
市場調査レポート
商品コード
1637067
医薬品ガラス包装の世界:製品タイプ・材料タイプ・用途・地域別の予測 (~2032年)Global Pharmaceutical Glass Packaging Market Research Report Information by Product Type, by Material Type, by Application, and by Region Market Forecast Till 2032 |
||||||
|
医薬品ガラス包装の世界:製品タイプ・材料タイプ・用途・地域別の予測 (~2032年) |
出版日: 2024年12月23日
発行: Market Research Future
ページ情報: 英文 143 Pages
納期: 即納可能
![]() |
世界の医薬品ガラス包装の市場規模は、2023年の213億5,420万米ドル、2024年の229億1,306万米ドルから、予測期間中は7.3%のCAGRで推移し、2032年には404億960万米ドルの規模に成長すると予測されています。
医薬品ガラス包装の市場は、新興国における医薬品産業の拡大、医薬品アイテムの拡張需要の高まり、偽造防止対策の重視などの要因に牽引されています。
地域別展望
北米地域が2023年に最大の市場シェアを占め、予測期間中も大幅なCAGR成長が見込まれています。北米の医薬品ガラス包装分野は、従来型医薬品の製造に向けた資金の増加により、今後も成長が進むでしょう。政府は慢性疾患の長期治療薬の開発に力を入れており、同地域の医薬用ガラス包装市場の進化を促すと予想されています。また、同地域には主要参入企業が存在することからも、今後10年間の収益は大幅に増加すると予想されています。
アジア太平洋地域は医薬品用ガラス包装市場で2番目に大きい地域です。医薬品ガラス包装の技術的進歩が進み、先進的な用途がもたらされているため、市場はさらに拡大しています。医薬用ガラス包装の需要は、市場拡大が著しいインドで急速に増加すると予想されています。
欧州の医薬品ガラス包装市場は、近年大幅な成長を遂げています。欧州では研究を基礎とする医薬品製造がもっとも注目されています。医薬品開発の発展は、この地域の患者の体調や生活の質を改善することを目的とした革新的な医薬品の探求、拡大、発表によって特徴付けられます。これらのことから、医薬品ガラス包装の生産も増加しています。
当レポートでは、世界の医薬品ガラス包装の市場を調査し、市場の定義と概要、市場成長への各種影響因子の分析、市場規模の推移・予測、各種区分・地域/主要国別の内訳、競合環境、主要企業のプロファイルなどをまとめています。
Global Pharmaceutical Glass Packaging Market Research Report Information by Product Type (Vials, Bottles & Jars, Cartridges & Syringes, Ampoules), by Material Type (Type I, Type II, Type III), by Application (Generic Drugs, Branded Drugs, Biological Drugs), and by Region (North America, Europe, Asia-Pacific, Middle East & Africa, and South America) Market Forecast Till 2032
In 2023, the pharmaceutical glass packaging market was estimated to be worth USD 21,354.2 million. The Global Pharmaceutical Glass Packaging industry is anticipated to experience a compound annual growth rate (CAGR) of 7.3% from USD 22,913.06 Million in 2024 to USD 40,409.6 Million by 2032.
The Pharmaceutical Glass Packaging Market is being led by the expansion of the pharmaceutical industry in emerging economies, the growing demand for pharmaceutical items to be extended, and the growing emphasis on anti-counterfeiting measures.
The Pharmaceutical Glass Packaging Market is being bolstered by the growing pharmaceutical industry in emerging economies and the heightened emphasis on anti-counterfeiting measures.
Market segment insights
The market is segmented into four categories: vials, bottles and canisters, cartridges and syringes, and ampoules, based on the type of product.
The market is segmented into type I, type II, and type III according to the type of material.
Generic drugs, branded drugs, and biological drugs comprise the application segment of the Pharmaceutical Glass Packaging Market size.
Regional Perspectives
The study offers market insights into North America, Europe, Asia-Pacific, Middle East & Africa, and South America by region. In 2023, the North American pharmaceutical glass packaging market held the largest market share and is anticipated to experience a substantial CAGR growth during the research period. The pharmaceutical glass packing sector in North America will experience development in the future due to the increase in funding to produce conventional medicines. The government's emphasis on the development of long-term drugs for chronic diseases is expected to drive the evolution of the pharmaceutical glass packaging market in the sub-continent. It is anticipated that the revenue of the regional market will be significantly increased over the next decade because of the presence of major participants in the region.
Additionally, Asia Pacific is the second-largest region in the Pharmaceutical Glass Packaging Market. The markets are further augmented by the increasing technological advancements in the glass packaging of medications, which are resulting in advanced uses. The demand for glass packaging is expected to increase swiftly in India, a prominent and expanding market for medications.
Furthermore, the pharmaceutical glass packaging market in Europe has experienced substantial growth in recent years. The financial system of Europe is most notable for its pharmaceutical manufacturing, which is founded on research. The escalation in medicinal development, which is characterized by the exploration, expansion, and presentation of innovative medications aimed at improving the physical condition and quality of life of patients in the region, is resulting in an increase in the production of pharmaceutical glass packaging.
Gerresheimer AG, Nipro Corporation, Schott Pharmaceutical Packaging, Stevanato Group, Bormioli Pharma S.P.A, West Pharmaceutical Services, Inc, PGP Glass, Stolzle-Oberglas Gmbh, Arab Pharmaceutical Glass Co, and Ajanta Bottle are among the main players in the market.